哈兽研品牌怎么样 申请店铺

我要投票 哈兽研在兽药行业中的票数:311 更新时间:2025-06-06
哈兽研是哪个国家的品牌?「哈兽研」是 哈尔滨维科生物技术有限公司 旗下著名品牌。该品牌发源于黑龙江哈尔滨市,由创始人付董在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力哈兽研品牌出海!将品牌入驻外推网,定制哈兽研品牌推广信息,可以显著提高哈兽研产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

哈兽研怎么样

成立于1992年,国内知名的全系列禽流感疫苗制造品牌,专业从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务的兽用生物制品企业


哈尔滨维科生物技术有限公司(简称维科生物)是中国农业科学院哈尔滨兽医研究所(简称哈兽研)独资的一人有限责任公司,是农业部禽流感疫苗生产企业和技术依托单位。

维科生物成立于1992年,专门从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务,是具有独立法人资格的企业,主要是对哈兽研科技成果进行孵化、转化及孵化后的推广。

维科生物现有员工中具有大专以上学历人员超过70%,其中高级职称人员4人,副高级职称人员21人,具有博士、硕士以上学位人员62人。中高级职称人员中,绝大多数是哈兽研所获科技成果的完成人。

公司新址落成于2008年,并于2009年7月整体通过农业部兽用生物制品GMP验收。新址园区面积约11.4万平方米,建筑面积6.2万平方米,共有17条生产线,主要设备为进口,自动化程度高,工艺优良。另有国家禽流感疫苗抗原储备库、质量检验、研发、动物实验、立体仓储等配套设施。

依托维科生物的黑龙江兽用生物制品工程技术研究中心与哈尔滨市兽用生物制品工程研究中心运行良好。经国家发改委立项与批准,维科生物参股组建的动物用生物制品国家工程研究中心也已正式运行。

维科生物生产的历代禽流感疫苗均在禽流感疫情防控中得到了广泛应用,解决了不同禽种的有效免疫问题,为我国禽流感疫情的防控做出重要贡献。目前维科生物的禽流感疫苗已在越南、埃及、印尼广泛应用。

我公司秉承“团结、奉献、求实、创新”的哈兽研精神,本着“责任重于泰山,细节决定成败”的企业文化理念,以维护动物健康和保障动物性食品安全为宗旨,以追踪兽用生物制品技术前沿为目标,高起点地为畜牧业发展服务,并努力将企业发展成为出色的兽用生物制品企业。


Founded in 1992, Harbin Weike Biotechnology Co., Ltd. (hereinafter referred to as "Weike biotechnology") is a famous brand of avian influenza vaccine manufacturing in China, specializing in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is a wholly-owned one person limited liability company of Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences (hereinafter referred to as "Harbin Veterinary Research") The company is an avian influenza vaccine manufacturer and technical support unit of the Ministry of agriculture. Founded in 1992, Vico biology specializes in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is an enterprise with independent legal personality, which mainly incubates, transforms and promotes the scientific and technological achievements of Harbin animal research. At present, more than 70% of the employees have college degree or above, including 4 with senior professional title, 21 with deputy senior professional title, 62 with doctor's degree or above. Most of the middle and senior professional titles are the Achievers of scientific and technological achievements of Harbin animal research institute. The company's new site was completed in 2008 and passed the GMP acceptance of animal biological products by the Ministry of agriculture in July 2009. The new site covers an area of about 114000 square meters, with a building area of 62000 square meters. There are 17 production lines. The main equipment is imported, with high degree of automation and excellent technology. There are also national avian influenza vaccine antigen storage, quality inspection, research and development, animal experiments, three-dimensional storage and other supporting facilities. Heilongjiang animal biological products engineering technology research center and Harbin animal biological products Engineering Research Center Based on Vico biology are in good operation. With the approval of the national development and Reform Commission, the National Engineering Research Center for animal biological products, which was established with the participation of Vico biology, has also been officially put into operation. All the avian influenza vaccines produced by Vico biology have been widely used in the prevention and control of avian influenza epidemic, which solved the effective immune problems of different avian species and made important contributions to the prevention and control of avian influenza epidemic in China. At present, the avian influenza vaccine of vyco has been widely used in Vietnam, Egypt and Indonesia. Our company adheres to the spirit of "unity, dedication, truth-seeking and innovation", the corporate culture concept of "responsibility is more important than Mount Tai, details determine success or failure", the purpose of maintaining animal health and ensuring animal food safety, the goal of tracking the forefront of animal biological products technology, the high starting point for animal husbandry development services, and strive to develop the enterprise into an excellent animal use Biological products enterprises.

本文链接: https://brand.waitui.com/19aeb19ab.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

大陆集团:未来独立运营的欧摩威集团任命执行董事会成员

大陆集团6月6日发布声明称,AUMOVIO欧摩威集团监事会正式确认未来独立的公司执行董事会成员的任命。除3月12日任命的首席执行官冯贺飞外,另有四位成员加入执行董事会:Ingo Holstein将出任首席人力资源官;冯贺飞将临时兼任首席财务官直至继任者到位;Boris Mergell、Jean-François Tarabbia和Ismail Dagli将分别负责安全与动态控制事业群、架构与网联方案事业群,以及自动驾驶及出行事业群三大业务板块。(界面)

48分钟前

阿特斯:股东拟减持不超3%公司股份

36氪获悉,阿特斯发布公告,股东无锡元禾重元优能创业投资合伙企业(有限合伙)持有公司3.57%股份,计划通过集中竞价减持公司股份不超过3688.22万股,即不超过公司总股本1%;通过大宗交易减持公司股份不超过7376.43万股,即不超过公司总股本2%。

48分钟前

深交所:本周共对80起证券异常交易行为采取了自律监管措施

36氪获悉,据深交所,6月3日至6月6日,本所共对80起证券异常交易行为采取了自律监管措施,涉及盘中拉抬打压、虚假申报等异常交易情形;共对14起上市公司重大事项进行核查,并上报证监会6起涉嫌违法违规案件线索。

48分钟前

融创中国:延长境外债务重组基础同意费截止日期

36氪获悉,融创中国在港交所公告,由于若干债权人需要更多时间完成加入重组支持协议的内部程序,应其要求与建议,公司将基础同意费截止日期由2025年6月6日香港时间下午五时正延长至2025年6月20日香港时间下午五时正。

48分钟前

沪市主板IPO新进展:一家受理一家过审

6月6日,上交所官网显示,重庆至信实业股份有限公司(简称:至信股份)主板IPO申请获得上交所受理。至信股份主营汽车冲焊件以及相关模具的开发、加工、生产和销售,是长安汽车、吉利汽车、长安福特、蔚来汽车、理想汽车、比亚迪、长城汽车等多家汽车制造厂商的一级供应商。同日,精密冲压模具生产销售企业江阴华新精密科技股份有限公司主板IPO申请也获得了上交所上市委审核通过。(证券时报)

48分钟前

本页详细列出关于哈兽研的品牌信息,含品牌所属公司介绍,哈兽研所处行业的品牌地位及优势。
咨询